|Bid||59.29 x 0|
|Ask||59.31 x 0|
|Day's Range||58.65 - 59.38|
|52 Week Range||49.31 - 80.91|
|Beta (5Y Monthly)||0.86|
|PE Ratio (TTM)||32.10|
|Earnings Date||Jun. 02, 2021 - Jun. 07, 2021|
|Forward Dividend & Yield||0.64 (1.08%)|
|Ex-Dividend Date||May 14, 2021|
|1y Target Est||75.40|
Underrated tech stocks like Enghouse Systems (TSX:ENGH) have been creating value for decades and deserve closer attention. The post $1,000 in This Underrated Tech Stock Would Be Worth $27,000 Today! appeared first on The Motley Fool Canada.
While Enghouse Systems Limited ( TSE:ENGH ) might not be the most widely known stock at the moment, it saw significant...
SINGAPORE, March 22, 2021 /CNW/ -- Xylonix, a Singapore-based biotech company, has developed a new immunity drug (010DS-Zn) that demonstrates potential for treating a variety of solid cancers and COVID-19's post-recovery complications, which include heart damage, diabetes and multi-system inflammatory syndrome in children (MIS-C). This research was recently submitted as a preprint publication on bioRxiv.